Scarica l'app Stockscreener
4.59
21.54%
-1.26
Dopo l'orario di chiusura:
4.64
0.05
+1.09%
Precedente Chiudi:
$5.85
Aprire:
$4.52
Volume 24 ore:
205.40K
Relative Volume:
0.31
Capitalizzazione di mercato:
$3.23M
Reddito:
-
Utile/perdita netta:
$-9.60M
Rapporto P/E:
-1.4525
EPS:
-3.16
Flusso di cassa netto:
$-8.96M
1 W Prestazione:
-20.45%
1M Prestazione:
-50.38%
6M Prestazione:
-12.57%
1 anno Prestazione:
-31.71%
Intervallo 1D:
$4.42
$4.8867
Intervallo di 1 settimana:
$4.42
$5.99
Portata 52W:
$4.20
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Nome
Artelo Biosciences Inc
Settore
Industria
Telefono
858-925-7049
Indirizzo
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Confronta ARTL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
4.59 | 11.48M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2021-02-12 | Iniziato | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Borsa (ARTL) Ultime notizie
Is Artelo Biosciences Inc. stock a top momentum playWeekly Earnings Recap & Weekly Breakout Opportunity Watchlist - newser.com
Artelo Biosciences Announces Pricing of $2.0 Million Public Offering - GlobeNewswire
Artelo Biosciences prices $2 million public offering of common stock By Investing.com - Investing.com Australia
$2 Million Capital Raise: Artelo Biosciences Prices Public Offering for Cancer Drug Development - Stock Titan
Form 424B5 ARTELO BIOSCIENCES, INC. - StreetInsider
Candlestick signals on Artelo Biosciences Inc. stock todayWeekly Profit Summary & Daily Volume Surge Trade Alerts - newser.com
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga
Is Artelo Biosciences Inc. stock a defensive play in 20252025 Momentum Check & Consistent Profit Trading Strategies - newser.com
How Artelo Biosciences Inc. stock performs during Fed tightening cyclesQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
When is the best time to exit Artelo Biosciences Inc.Day Trade & Community Consensus Trade Alerts - newser.com
Artelo Biosciences launches underwritten public offering of stock - Investing.com India
Artelo Biosciences, Inc. Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Artelo Biosciences Announces Proposed Underwritten Public Offering - GlobeNewswire
Nasdaq-Listed Biotech Artelo Biosciences Announces New Public Stock Offering for Cancer Research - Stock Titan
Can Artelo Biosciences Inc. stock surprise with earnings upsideWeekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Statistical indicators supporting Artelo Biosciences Inc.’s strengthJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com
How to track smart money flows in Artelo Biosciences Inc.Weekly Profit Report & Fast Exit and Entry Strategy Plans - newser.com
Artelo Biosciences (ARTL) Shares Promising Interim Data from Pha - GuruFocus
Artelo Biosciences Announces Presentation of Positive - GlobeNewswire
Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference - MarketScreener
6% Weight Gain: Artelo's Cancer Cachexia Drug Shows Promising Results in Phase 2 Trial with Activity Boost - Stock Titan
Visual trend scoring systems applied to Artelo Biosciences Inc.Gold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Is Artelo Biosciences Inc. stock a safe haven assetEarnings Risk Summary & Growth Focused Stock Reports - newser.com
How to integrate Artelo Biosciences Inc. into portfolio analysis toolsTrade Performance Summary & Low Drawdown Investment Ideas - newser.com
Aug PreEarnings: What is Artelo Biosciences Incs TAM Total Addressable MarketQuarterly Profit Review & Verified Short-Term Plans - خودرو بانک
Can Artelo Biosciences Inc. continue delivering strong returnsPortfolio Risk Report & Verified High Yield Trade Plans - خودرو بانک
Artelo Biosciences Inc Azioni (ARTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):